Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Spero Therapeutics, Inc. | 1,886,077 | reported | 05 Feb 2025 | tx 20+2,153,136−288,063 |
| Alaunos Therapeutics, Inc. | 80,500 | reported | 29 Jan 2020 | tx 3+604,400 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Feb 2025 | SALE | Spero Therapeutics, Inc. | 106,408 | 0.78 USD | |
| 05 Feb 2025 | SALE | Spero Therapeutics, Inc. | 42,786 | 0.78 USD | |
| 05 Feb 2025 | SALE | Spero Therapeutics, Inc. | 6,139 | 0.78 USD | |
| 03 Feb 2025 | GRANT_AWARD | Spero Therapeutics, Inc. | 751,407 | 0.00 USD | |
| 27 Aug 2024 | SALE | Spero Therapeutics, Inc. | 2,757 | 1.35 USD | |
| 02 Aug 2024 | SALE | Spero Therapeutics, Inc. | 14,800 | 1.32 USD | |
| 05 Aug 2024 | SALE | Spero Therapeutics, Inc. | 17,641 | 1.31 USD | |
| 01 Feb 2024 | GRANT_AWARD | Spero Therapeutics, Inc. | 679,501 | 0.00 USD | |
| 05 Feb 2024 | SALE | Spero Therapeutics, Inc. | 45,093 | 1.45 USD | |
| 02 Feb 2024 | SALE | Spero Therapeutics, Inc. | 30,901 | 1.37 USD | |
| 29 Aug 2023 | SALE | Spero Therapeutics, Inc. | 4,163 | 1.30 USD | |
| 28 Aug 2023 | SALE | Spero Therapeutics, Inc. | 1,854 | 1.26 USD | |
| 01 Aug 2023 | GRANT_AWARD | Spero Therapeutics, Inc. | 266,000 | 0.00 USD | |
| 02 Feb 2023 | SALE | Spero Therapeutics, Inc. | 9,504 | 1.83 USD | |
| 01 Feb 2023 | GRANT_AWARD | Spero Therapeutics, Inc. | 265,957 | 0.00 USD | |
| 29 Aug 2022 | SALE | Spero Therapeutics, Inc. | 6,017 | 0.89 USD | |
| 01 Feb 2022 | GRANT_AWARD | Spero Therapeutics, Inc. | 38,014 | 0.00 USD | |
| 01 Feb 2022 | GRANT_AWARD | Spero Therapeutics, Inc. | 53,190 | 0.00 USD | deriv |
| 26 Aug 2021 | GRANT_AWARD | Spero Therapeutics, Inc. | 24,067 | 0.00 USD | |
| 04 Jan 2021 | GRANT_AWARD | Spero Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 29 Jan 2020 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 80,500 | 0.00 USD | |
| 29 Jan 2020 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 123,900 | 0.00 USD | deriv |
| 22 Jul 2019 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 400,000 | 0.00 USD | deriv |